NYSE · CIK 0001326205
IGC IGC Pharma, Inc.
Insider trading from SEC Form 4. Last filing 14 d ago.
IGC Pharma, Inc. (IGC) has 13 SEC Form 4 filings on file from 5 insiders, the latest filed on Sep 29, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at IGC Pharma, Inc., scored.
Transactions
Every row filed, 37 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Ram Mukunda CEO | GGift Common Stock | -100,000 | $0.00 | $0 | 6,775,563 | 14 d ago |
| Sep 25, 2026 | Claudia Grimaldi PFO | GGift Common Stock | -150,000 | $0.00 | $0 | 3,271,092 | 14 d ago |
| Sep 25, 2026 | Ram Mukunda CEO | GGift Common Stock | -100,000 | $0.00 | $0 | 6,675,563 | 14 d ago |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Common Stock | +333,333 | $0.00 | $0 | 4,326,011 | Apr 6, 2026 |
| Apr 1, 2026 | Richard K Prins director | MOption exercise Common Stock | +100,000 | $0.00 | $0 | 1,471,251 | Apr 6, 2026 |
| Apr 1, 2026 | James P Moran director | MOption exercise Common Stock | +80,000 | $0.00 | $0 | 1,185,735 | Apr 6, 2026 |
| Apr 1, 2026 | Claudia Grimaldi PFO | MOption exercise Common Stock | +100,000 | $0.00 | $0 | 1,234,252 | Apr 6, 2026 |
| Apr 1, 2026 | James P Moran director | MOption exercise Common Stock | +50,000 | $0.00 | $0 | 1,235,735 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Common Stock | +323,077 | $0.26 | $84k | 4,649,088 | Apr 6, 2026 |
| Apr 1, 2026 | Richard K Prins director | MOption exercise Common Stock | +70,000 | $0.00 | $0 | 1,541,251 | Apr 6, 2026 |
| Apr 1, 2026 | Claudia Grimaldi PFO | MOption exercise Common Stock | +138,462 | $0.26 | $36k | 1,372,714 | Apr 6, 2026 |
| Apr 1, 2026 | Claudia Grimaldi PFO | MOption exercise Restricted Stock Unitsderivative | -100,000 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | James P Moran director | MOption exercise Restricted Stock Unitsderivative | -80,000 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | Richard K Prins director | MOption exercise Restricted Stock Unitsderivative | -100,000 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Common Stockindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 877,419 | Apr 6, 2026 |
| Apr 1, 2026 | Richard K Prins director | MOption exercise Restricted Stock Unitsderivative | -70,000 | $0.00 | $0 | 70,000 | Apr 6, 2026 |
| Apr 1, 2026 | Claudia Grimaldi PFO | MOption exercise Optionsderivative | -138,462 | $0.00 | $0 | 221,538 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Common Stockindirect: BY SPOUSE | +33,332 | $0.00 | $0 | 910,751 | Apr 6, 2026 |
| Apr 1, 2026 | James P Moran director | MOption exercise Restricted Stock Unitsderivative | -50,000 | $0.00 | $0 | 50,000 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Restricted Stock Unitsderivative | -333,333 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Optionsderivative | -323,077 | $0.00 | $0 | 676,925 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -16,667 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | Ram Mukunda CEO | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -33,332 | $0.00 | $0 | 33,334 | Apr 6, 2026 |
| Feb 3, 2026 | Ram Mukunda CEO | MOption exercise Common Stockindirect: BY SPOUSE | +50,000 | $0.00 | $0 | 860,752 | Feb 4, 2026 |
| Feb 3, 2026 | Ram Mukunda CEO | AGrant or award Restricted Stock Unitsderivativeindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 16,667 | Feb 4, 2026 |
| Feb 3, 2026 | Ram Mukunda CEO | AGrant or award Restricted Stock Unitsderivativeindirect: BY SPOUSE | +66,666 | $0.00 | $0 | 66,666 | Feb 4, 2026 |
| Jan 19, 2026 | Richard K Prins director | MOption exercise Common Stock | +100,000 | $0.00 | $0 | 1,371,251 | Jan 20, 2026 |
| Jan 19, 2026 | Richard K Prins director | MOption exercise Restricted Stock Unitsderivative | -100,000 | $0.00 | $0 | 50,000 | Jan 20, 2026 |
| Oct 17, 2025 | Richard K Prins director | AGrant or award Optionsderivative | +750,000 | $0.00 | $0 | 750,000 | Oct 22, 2025 |
| Oct 17, 2025 | Claudia Grimaldi PFO | GGift Common Stock | -50,000 | $0.00 | $0 | 1,134,252 | Oct 21, 2025 |
| Oct 17, 2025 | Terry L Lierman director | AGrant or award Optionsderivative | +500,000 | $0.00 | $0 | 500,000 | Oct 21, 2025 |
| Oct 17, 2025 | James P Moran director | AGrant or award Optionsderivative | +500,000 | $0.00 | $0 | 500,000 | Oct 21, 2025 |
| Oct 17, 2025 | Claudia Grimaldi PFO | AGrant or award Optionsderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Oct 21, 2025 |
| Oct 17, 2025 | Claudia Grimaldi PFO | AGrant or award Optionsderivative | +500,000 | $0.00 | $0 | 500,000 | Oct 21, 2025 |
| Oct 17, 2025 | Ram Mukunda CEO | GGift Common Stock | -100,000 | $0.00 | $0 | 3,992,678 | Oct 20, 2025 |
| Oct 17, 2025 | Ram Mukunda CEO | AGrant or award Optionsderivative | +3,000,000 | $0.00 | $0 | 3,000,000 | Oct 20, 2025 |
| Oct 17, 2025 | Ram Mukunda CEO | AGrant or award Optionsderivative | +1,500,000 | $0.00 | $0 | 1,500,000 | Oct 20, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Claudia GrimaldiPFO
- Terry L Liermandirector
- James P Morandirector
- Ram MukundaCEO
- Richard K Prinsdirector
Questions about IGC
Answered from the filings on this page, as of the latest one.
Are insiders buying IGC?
No. In the last 90 days no insider at IGC Pharma, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade IGC on the open market?
No open-market trade has been scored at IGC Pharma, Inc.. The latest Form 4 on file was filed on Sep 29, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at IGC Pharma, Inc.?
5 people have filed a Form 4 at IGC Pharma, Inc., among them Claudia Grimaldi (PFO), Terry L Lierman (director), James P Moran (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.